SEER, INC. (SEER) Gross Margin
- Gross margin · 12 months: Value 47.70%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 47.70% | Gross profit / revenue. Period ending 2026-06-30. $6.78M ÷ $14.22M × 100 ≈ 47.70% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 6.78M USD | Gross Profit |
| Revenue | 14.22M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $6.78M | $14.22M | (m) | 47.70% |
| 2026-03-31 | $7.39M | $15.17M | (m) | 48.70% |
| 2025-12-31 | $8.46M | $16.58M | (m) | 51.06% |
| 2025-09-30 | $8.31M | $16.38M | (m) | 50.72% |
| 2025-06-30 | $8.13M | $16.29M | (m) | 49.94% |
| 2025-03-31 | $7.75M | $15.31M | (m) | 50.66% |
| 2024-12-31 | $7.05M | $14.17M | (m) | 49.79% |
| 2024-09-30 | $7.03M | $14.61M | (m) | 48.13% |
| 2024-06-30 | $7.25M | $14.74M | (m) | 49.19% |
| 2024-03-31 | $7.80M | $15.67M | (m) | 49.76% |
| 2023-12-31 | $8.51M | $16.66M | (m) | 51.05% |
| 2023-09-30 | $8.80M | $16.83M | (m) | 52.29% |
| 2023-06-30 | $8.59M | $16.62M | (m) | 51.67% |
| 2023-03-31 | $7.92M | $16.23M | (m) | 48.77% |
| 2022-12-31 | $7.09M | $15.49M | (m) | 45.78% |
| 2022-09-30 | $6.23M | $13.95M | (m) | 44.65% |
| 2022-06-30 | $5.46M | $12.15M | (m) | 44.89% |
| 2022-03-31 | $4.59M | $9.87M | (m) | 46.56% |
| 2021-12-31 | $3.41M | $6.62M | (m) | 51.56% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $656.00K | $656.00K | (m) | 100.00% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |